Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies

Monitoring Residual Disease in the Ph-Negative Myeloproliferative Neoplasms Post-Allogeneic Stem Cell Transplantation: More Mutations and More Methodologies

Bibliographic Details
Main Authors:	Langabeer, Stephen E., Haslam, Karl, Conneally, Eibhlin
Format:	Online
Language:	English
Published:	Frontiers Media S.A. 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126362/

Similar Items

Allogeneic Hematopoietic Stem Cell Transplantation for a BCR-FGFR1 Myeloproliferative Neoplasm Presenting as Acute Lymphoblastic Leukemia
by: Haslam, Karl, et al.
Published: (2012)

Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches
by: Haslam, Karl, et al.
Published: (2016)

Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation
by: Langabeer, Stephen E., et al.
Published: (2015)

Allogeneic hematopoietic cell transplantation in adult patients with myelodysplastic/myeloproliferative neoplasms
by: Lim, Sung-Nam, et al.
Published: (2013)

Presence of Polyclonal Hematopoiesis in Females with Ph-negative Myeloproliferative Neoplasms
by: Swierczek, Sabina, et al.
Published: (2015)

Philadelphia-negative chronic myeloproliferative neoplasms
by: Bittencourt, Rosane Isabel, et al.
Published: (2012)

Molecular biology of Philadelphia-negative myeloproliferative neoplasms
by: Campregher, Paulo Vidal, et al.
Published: (2012)

CALR mutation analysis is not indicated in patients with splanchnic vein thrombosis without evidence of a myeloproliferative neoplasm: a micro-review
by: Langabeer, Stephen E.
Published: (2016)

The Hematopoietic Niche in Myeloproliferative Neoplasms
by: Schmitt-Graeff, Annette H., et al.
Published: (2015)

Guidelines for the management of myeloproliferative neoplasms
by: Choi, Chul Won, et al.
Published: (2015)

Calreticulin Mutations in Myeloproliferative Neoplasms
by: Lavi, Noa
Published: (2014)

Apoptosis deregulation in myeloproliferative neoplasms
by: Tognon, Raquel, et al.
Published: (2013)

In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical Phenotypes
by: Balduini, Alessandra, et al.
Published: (2011)

Ph-Negative Chronic Myeloproliferative Neoplasm (Primary Myelofibrosis) – as One of the Reasons of the Budd-Chiari Syndrome
by: Sokolova, M., et al.
Published: (2012)

TET2 Mutations in Ph-Negative Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings
by: Patriarca, Andrea, et al.
Published: (2013)

Genetic–pathologic characterization of myeloproliferative neoplasms
by: Kim, Yonggoo, et al.
Published: (2016)

Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
by: Barcelos, Michelle Maccarini, et al.
Published: (2011)

Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms
by: Pandey, Ruchi, et al.
Published: (2015)

Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
by: Kaplan, Jason B., et al.
Published: (2016)

Mouse models of myeloproliferative neoplasms: JAK of all grades
by: Li, Juan, et al.
Published: (2011)

Characteristics of the four subtypes of myelodysplastic/myeloproliferative neoplasms
by: WU, HUANLING, et al.
Published: (2013)

Targeting Rho Associated Kinases in Leukemia and Myeloproliferative Neoplasms
by: Mali, Raghuveer Singh, et al.
Published: (2012)

Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives
by: Vannucchi, Alessandro M, et al.
Published: (2009)

p53 as a target in myeloproliferative neoplasms
by: Lu, Min, et al.
Published: (2012)

Targeting SHP2 phosphatase in Myeloproliferative Neoplasms
by: Mali, Raghuveer Singh, et al.
Published: (2012)

Portal Hypertension and Myeloproliferative Neoplasms: A Relationship Revealed
by: Toros, Ahmet Burak, et al.
Published: (2013)

Myeloproliferative neoplasms in five multiple sclerosis patients☆
by: Thorsteinsdottir, Sigrun, et al.
Published: (2013)

AKT is a therapeutic target in myeloproliferative neoplasms
by: Khan, Irum, et al.
Published: (2013)

Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
by: Bing Li, et al.
Published: (2017-05-01)

Hypothetical Atopic Dermatitis-Myeloproliferative Neoplasm Syndrome
by: Kawakami, Toshiaki, et al.
Published: (2015)

The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia
by: Birgegård, Gunnar
Published: (2016)

Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience
by: Begna, K, et al.
Published: (2016)

Mediators of Inflammation in Myeloproliferative Neoplasms: State of the Art
by: Hermouet, Sylvie, et al.
Published: (2015)

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview
by: de Freitas, Renata Mendes, et al.
Published: (2015)

Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
by: Hoermann, Gregor, et al.
Published: (2015)

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development
by: Geyer, Holly L., et al.
Published: (2015)

Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm
by: Fleischman, Angela G.
Published: (2015)

Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation
by: Hermouet, Sylvie, et al.
Published: (2015)

Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms
by: Eliaçık, Eylem, et al.
Published: (2015)

Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
by: Zielinska, Patrycja, et al.
Published: (2014)